287 related articles for article (PubMed ID: 23845326)
21. Circulating TGF-β1 levels are negatively correlated with sclerostin levels in early postmenopausal women.
Cheng Q; Tang W; Sheu TJ; Du Y; Gan J; Li H; Hong W; Zhu X; Xue S; Zhang X
Clin Chim Acta; 2016 Apr; 455():87-92. PubMed ID: 26826396
[TBL] [Abstract][Full Text] [Related]
22. Decreased Serum Insulin-like Growth Factor-I is a Risk Factor for Non-vertebral Fractures in Diabetic Postmenopausal Women.
Miyake H; Kanazawa I; Sugimoto T
Intern Med; 2017; 56(3):269-273. PubMed ID: 28154269
[TBL] [Abstract][Full Text] [Related]
23. Vertebral fracture prevalence among Greek healthy middle-aged postmenopausal women: association with demographics, anthropometric parameters, and bone mineral density.
Lambrinoudaki I; Flokatoula M; Armeni E; Pliatsika P; Augoulea A; Antoniou A; Alexandrou A; Creatsa M; Panoulis C; Dendrinos S; Papacharalambous X
Spine J; 2015 Jan; 15(1):86-94. PubMed ID: 25106754
[TBL] [Abstract][Full Text] [Related]
24. Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.
Rossini M; Viapiana O; Idolazzi L; Ghellere F; Fracassi E; Troplini S; Povino MR; Kunnathully V; Adami S; Gatti D
Calcif Tissue Int; 2016 May; 98(5):438-45. PubMed ID: 26645432
[TBL] [Abstract][Full Text] [Related]
25. Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes.
Yamaguchi T; Kanazawa I; Yamamoto M; Kurioka S; Yamauchi M; Yano S; Sugimoto T
Bone; 2009 Aug; 45(2):174-9. PubMed ID: 19446053
[TBL] [Abstract][Full Text] [Related]
26. Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
van Lierop AH; Hamdy NA; van der Meer RW; Jonker JT; Lamb HJ; Rijzewijk LJ; Diamant M; Romijn JA; Smit JW; Papapoulos SE
Eur J Endocrinol; 2012 Apr; 166(4):711-6. PubMed ID: 22267280
[TBL] [Abstract][Full Text] [Related]
27. Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus.
García-Martín A; Rozas-Moreno P; Reyes-García R; Morales-Santana S; García-Fontana B; García-Salcedo JA; Muñoz-Torres M
J Clin Endocrinol Metab; 2012 Jan; 97(1):234-41. PubMed ID: 22031520
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus.
Raška I; Rašková M; Zikán V; Škrha J
Cent Eur J Public Health; 2017 Mar; 25(1):3-10. PubMed ID: 28399348
[TBL] [Abstract][Full Text] [Related]
29. The presence and severity of vertebral fractures is associated with the presence of esophageal hiatal hernia in postmenopausal women.
Yamaguchi T; Sugimoto T; Yamada H; Kanzawa M; Yano S; Yamauchi M; Chihara K
Osteoporos Int; 2002; 13(4):331-6. PubMed ID: 12030548
[TBL] [Abstract][Full Text] [Related]
30. Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.
Atteritano M; Di Mauro E; Canale V; Bruzzese AM; Ricciardi CA; Cernaro V; Lacquaniti A; Buemi M; Santoro D
Osteoporos Int; 2017 Feb; 28(2):577-584. PubMed ID: 27682249
[TBL] [Abstract][Full Text] [Related]
31. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.
Anastasilakis AD; Polyzos SA; Gkiomisi A; Bisbinas I; Gerou S; Makras P
J Clin Endocrinol Metab; 2013 Aug; 98(8):3206-12. PubMed ID: 23788684
[TBL] [Abstract][Full Text] [Related]
32. Higher Serum Uric Acid is a Risk Factor of Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes Mellitus.
Tanaka KI; Kanazawa I; Notsu M; Sugimoto T
Exp Clin Endocrinol Diabetes; 2020 Jan; 128(1):66-71. PubMed ID: 30562825
[TBL] [Abstract][Full Text] [Related]
33. Volumetric femoral BMD, bone geometry, and serum sclerostin levels differ between type 2 diabetic postmenopausal women with and without fragility fractures.
Heilmeier U; Carpenter DR; Patsch JM; Harnish R; Joseph GB; Burghardt AJ; Baum T; Schwartz AV; Lang TF; Link TM
Osteoporos Int; 2015 Apr; 26(4):1283-93. PubMed ID: 25582311
[TBL] [Abstract][Full Text] [Related]
34. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
Voskaridou E; Christoulas D; Plata E; Bratengeier C; Anastasilakis AD; Komninaka V; Kaliontzi D; Gkotzamanidou M; Polyzos SA; Dimopoulou M; Terpos E
Horm Metab Res; 2012 Nov; 44(12):909-13. PubMed ID: 22581647
[TBL] [Abstract][Full Text] [Related]
35. Role of sclerostin in the bone loss of postmenopausal chinese women with type 2 diabetes.
Zhou YJ; Li A; Song YL; Zhou H; Li Y; Tang YS
Chin Med Sci J; 2013 Sep; 28(3):135-9. PubMed ID: 24074614
[TBL] [Abstract][Full Text] [Related]
36. The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus.
Gaudio A; Privitera F; Pulvirenti I; Canzonieri E; Rapisarda R; Fiore CE
Diab Vasc Dis Res; 2014 Jan; 11(1):48-52. PubMed ID: 24227537
[TBL] [Abstract][Full Text] [Related]
37. Association of circulating sclerostin levels with fat mass and metabolic disease--related markers in Japanese postmenopausal women.
Urano T; Shiraki M; Ouchi Y; Inoue S
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1473-7. PubMed ID: 22639287
[TBL] [Abstract][Full Text] [Related]
38. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
[TBL] [Abstract][Full Text] [Related]
39. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of vertebral fractures and serum sclerostin levels in acromegaly.
Uygur MM; Yazıcı DD; Buğdaycı O; Yavuz DG
Endocrine; 2021 Sep; 73(3):667-673. PubMed ID: 34019235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
